Searchable abstracts of presentations at key conferences in endocrinology

ea0020p588 | Neuroendocrinology, Pituitary and Behaviour | ECE2009

Quality of life (QoL) in patients with Cushing's syndrome in a Spanish population: new experience with the CushingQoL questionnaire

Alicia Santos , Eugenia Resmini , Jose Barahona Ma , Camelia Marti , Cheryl Farkas , Olga Roig , Ma Antonia Martinez , Nuria Sucunza , Xavier Badia , Susan M Webb

Quality of life is impaired in patients who have suffered Cushing’s syndrome (CS).Aim: Evaluate QoL with the new questionnaire CushingQoL in Spanish patients in a clinical practice setting and compare it with a generic QoL questionnaire, EuroQoL-5 Dimensions (5D) and its Visual Analogue Scale (VAS).Patients and methods: Forty-three patients with CS (38 pituitary-dependent, 28 cured) were approached during their regular endocri...

ea0056gp207 | Pituitary Clinical | ECE2018

Molecular profiling of non-functioning pituitary adenomas does not support pharmacological therapeutic options

Gil Joan , Blanco Alberto , Serra Guillermo , Salinas Isabel , Webb Susan M , Hostalot Cristina , Obiols Gabriel , Valassi Elena , Roig Olga , Sesmilo Gemma , Villabona Carles , Jorda Mireia , Puig-Domingo Manel

Non-functioning pituitary adenomas (NFPA) are the most common pituitary tumours. They usually come to medical attention because of a mass effect and/or hypopituitarism. Tumour shrinkage during therapy with either dopamine agonists (DA) or somatostatin analogues (SSA) has been previously reported in some cases; however, response of NFPA to medical treatment is still poor and unpredictable. Our aim was to explore the molecular mechanisms underlying this lack of efficacy through ...